SCHEMBL667201

SCHEMBL667201

COc1cc(C=O)ccc1OC1CCCCO1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
TSHR P16473 1/20 0.54
PDE4B Q07343 3/20 0.54
FDPS P14324 1/20 0.48
TTR P02766 1/20 0.45
PTPN1 P18031 2/20 0.44
ALDH1A3 P47895 1/20 0.44
AOX1 Q06278 1/20 0.43
TRIM24 O15164 1/20 0.43
HPGD P15428 1/20 0.43
ALDH5A1 P51649 1/20 0.43
ABAT P80404 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TRIM33 Q9UPN9 1/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.41
NPC1 O15118 1/20 0.41
PDE3A Q14432 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL998425 0.95 PDE4B (0.59) ALDH1A1TSHRPDE4BFDPSTTR
SCHEMBL3359792 0.92 PDE4B (0.49) ALDH1A1TSHRPDE4BFDPSPTPN1
SCHEMBL3594038 0.91 PDE4B (0.64) ALDH1A1TSHRPDE4BFDPSTTR
SCHEMBL24366316 0.88 PDE4B (0.55) ALDH1A1TSHRPDE4BPTPN1KDM4E
SCHEMBL24588569 0.87 PDE4B (0.51) ALDH1A1TSHRPDE4BPTPN1HPGD
SCHEMBL5863923 0.85 PDE4B (0.47) ALDH1A1TSHRPDE4BPTPN1ALDH1A3
SCHEMBL3362581 0.84 PDE4B (0.45) ALDH1A1TSHRPDE4BPTPN1ALDH1A3
SCHEMBL24367560 0.83 KDM4E (0.60) ALDH1A1PDE4BPTPN1HPGDKDM4E
SCHEMBL31428576 0.83 FDPS (0.61) ALDH1A1TSHRFDPSHPGDTDP1
SCHEMBL9013036 0.83 KDM4E (0.60) ALDH1A1PDE4BPTPN1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844846-B2 Styrylbenzothiazole derivatives and uses in imaging methods EMORY UNIVERSITY (US) 2023-12-19 US disclosed
CN-108516929-B 2-methylene- (3-methoxy-4-hydroxy) -benzyl-1-indanone analogue and application thereof 温州医科大学 2021-06-18 CN disclosed
EP-3793619-A1 STYRYLBENZOTHIAZOLE DERIVATIVES AND USES IN IMAGING Emory University (US) 2021-03-24 EP disclosed
CN-112105393-A Styrylbenzothiazole derivatives and use in imaging 爱默蕾大学 2020-12-18 CN disclosed
EP-3564204-A1 1,5-DIPHENYL-PENTA-1,4-DIEN-3-ONE COMPOUNDS The University of Tokyo (JP) 2019-11-06 EP disclosed
EP-3045445-B1 1,5-DIPHENYL-PENTA-1,4-DIEN-3-ONE COMPOUNDS UNIV TOKYO (JP) 2019-08-07 EP disclosed
EP-2606021-B1 1,5-DIPHENYL-PENTA-1,4-DIEN-3-ONE COMPOUNDS UNIV TOKYO (JP) 2019-07-31 EP disclosed
EP-3045445-A1 1,5-DIPHENYL-PENTA-1,4-DIEN-3-ONE COMPOUNDS THE UNIVERSITY OF TOKYO (JP) 2016-07-20 EP disclosed
US-9359279-B2 Treatment of cancer, inflammatory disease, and autoimmune disease ALLIANZ PHARMASCIENCE LTD. (TW) 2016-06-07 US disclosed
US-20160039734-A1 THERAPEUTIC CURCUMIN DERIVATIVES STC UNM (US) 2016-02-11 US disclosed
WO-2012024282-A2 1,5-DIPHENYL-PENTA-1,4-DIEN-3-ONE COMPOUNDS SHIH CHARLES C-Y (US) 2012-02-23 WO disclosed
US-7728043-B2 Methods for treatment of beta-amyloid protein-induced ocular disease KIM DARRICK S H L 2010-06-01 US disclosed
WO-2010046926-A2 NOVEL STILBENE ANALOGS APTUIT LAURUS PVT LTD (IN) 2010-04-29 WO disclosed
US-20070128658-A1 FLUORESCENT DYES, METHODS AND USES THEREOF WISCONSIN ALUMNI RESEARCH FOUNDATION 2007-06-07 US disclosed
US-20070060644-A1 Therapeutic curcumin derivatives STC.UNM 2007-03-15 US disclosed
US-20070060644-A1 Therapeutic curcumin derivatives STC.UNM 2007-03-15 US disclosed
US-20070003641-A1 Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease KIM DARRICK S H 2007-01-04 US disclosed
EP-0705817-A1 New cannamide derivatives and their use as allergy inhibitors TSUMURA & CO. (JP) 1996-04-10 EP disclosed
US-5344845-A Methyl 4(4-acetoxy-3-methoxycinnamanide and salts as an immunosuppressive drug for allergic reactions TSUMURA & CO. (JP) 1994-09-06 US disclosed
EP-0535250-A1 NOVEL COMPOUNDS AND USE THEREOF AS MEDICINE TSUMURA & CO. (JP) 1993-04-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070003641-A1 Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease APP, BACE1, GSAP ALDH1A1 2716/4885TSHR 4196/4885PDE4B 3947/4885
US-20160039734-A1 THERAPEUTIC CURCUMIN DERIVATIVES FABP2, GLS2, FABP1 ALDH1A1 670/4885TSHR 4278/4885PDE4B 3587/4885
US-20070060644-A1 Therapeutic curcumin derivatives FABP2, GLS2, FABP1 ALDH1A1 670/4885TSHR 4278/4885PDE4B 3587/4885
US-11844846-B2 Styrylbenzothiazole derivatives and uses in imaging methods SNCA, NLN, SMN1; SMN2 ALDH1A1 1535/4885TSHR 3678/4885PDE4B 1161/4885
US-20070128658-A1 FLUORESCENT DYES, METHODS AND USES THEREOF DHX15, DHX35, DUT ALDH1A1 2503/4885TSHR 2263/4885PDE4B 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.